AndrewSatlinMD

Psychiatry • New York, NY

Geriatric Psychiatry

Chief Medical Officer at Transposon Therapeutics

Join to view full profile

Dr. Satlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Satlin's full profile

Already have an account?

Office
239 Central Park West
#5C
New York, NY 10024
Phone+1 973-978-5741

Education & Training

Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1980 - 1983
New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1979 - 1980
Harvard Medical SchoolClass of 1979

Certifications & Licensure

MA State Medical License 1981 - 2025
American Board of Psychiatry and Neurology Psychiatry

Publications & Presentations

PubMed

5 citations
Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial.
Trisha Suppes, Suresh Durgam, Susan G Kozauer, Richard Chen, Hassan D Lakkis
Bipolar Disorders. 2023-09-01
48 citations
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
Joseph R. Calabrese, Suresh Durgam, Andrew Satlin, Kimberly E. Vanover, Robert E. Davis
The American Journal of Psychiatry. 2021-09-23
12 citations
Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure
Nisha A. Gilotra, Adam D. DeVore, Thomas J. Povsic, Allison G. Hays, Virginia S. Hahn
Circulation. Heart Failure. 2021-08-31

Press Mentions

Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical OfficerOctober 1st, 2020
Efficacy and Safety of Lumateperone for Treatment of SchizophreniaJanuary 8th, 2020
Intra-Cellular Therapies Expands Its Executive Team with the Appointment of Dr. Andrew Satlin as Executive Vice President and Chief Medical OfficerNovember 13th, 2017

Grant Support

Senile Changes In Circadian Rhythms And BehaviorNational Institute On Aging1995–1996
Circadian Locomoter And Temperature Rhythms In Alzheimer'S DiseaseNational Center For Research Resources1993
Senile Changes In Circadian Rhythems And BehaviorNational Institute On Aging1990–1992
Academic Award--NiaNational Institute On Aging1989
Academic Award - National Institute Of AgingNational Institute On Aging1985–1988